Brewin Dolphin Wealth Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-745
Closed -$141K 342
2021
Q2
$141K Hold
745
0.02% 146
2021
Q1
$97K Hold
745
0.01% 141
2020
Q4
$77.3K Hold
745
0.01% 143
2020
Q3
$56.5K Hold
745
0.01% 151
2020
Q2
$35.3K Buy
+745
New +$30.7K 0.01% 175

Other funds holding SWAV

Brewin Dolphin Wealth Management's SWAV Position: Q3 2021 in Review

Brewin Dolphin Wealth Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q3 2021, closing a stake of 745 shares — an estimated $141K sold.

Brewin Dolphin Wealth Management first reported a position in SWAV in Q2 2020 and held it in 5 quarters. The position peaked at $141K in Q2 2021. 266 funds tracked by Wall St. Rank hold SWAV as of Q3 2021.

  • Brewin Dolphin Wealth Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Brewin Dolphin Wealth Management sold 745 Shockwave Medical, Inc. Common Stock shares in Q3 2021, an estimated $141K.
  • Brewin Dolphin Wealth Management first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2020 and held it in 5 quarters.
  • Brewin Dolphin Wealth Management's Shockwave Medical, Inc. Common Stock position peaked at $141K in Q2 2021.
  • 266 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q3 2021.

Based on Brewin Dolphin Wealth Management's 13F filing for Q3 2021, filed 9 Nov 2023.